NCT00772031

NINDS CRC Chronic Migraine Treatment Trial

NINDS Clinical Research Collaboration Chronic Migraine Treatment Trial

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 191 (actual)
• Sponsor: Anne Lindblad · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the reduction in the number of severe headache days at six months in people with chronic migraine treated with topiramate and propranolol versus those treated with topiramate and a placebo.

Detailed description

Chronic migraine affects about 2 percent of all adults. Currently there are no effective preventative treatments to deal with this disabling condition. Three randomized, placebo-controlled trials found that topiramate was an effective, safe and generally well-tolerated drug for treating chronic migraine. As a result of these trials, topiramate is becoming the standard treatment among headache specialists. Experts agree that treatment with combinations of preventive agents is required in the majority of individuals with chronic migraine for maximal headache relief. No randomized trials have assessed the value of frequently used combinations of preventive agents for chronic migraine. The goal of this trial is to determine if adding a second drug to topiramate treatment will further reduce the headache burden for people with this condition. In the study, 250 participants with chronic migraine will be randomized to two groups - treatment with topiramate and propranolol or topiramate and placebo. Participants will be followed for six months.

Conditions

• Chronic Migraine

Interventions

Type	Name	Description
DRUG	propranolol LA	Propranolol LA up to 240 mg/day
DRUG	topiramate	Topiramate is an effective, safe and generally well-tolerated drug used for treating chronic migraine. It is becoming the standard treatment among headache specialists.
DRUG	placebo	an inactive substance

Timeline

• Start date: 2008-10-01
• Primary completion: 2010-09-01
• Completion: 2010-09-01
• First posted: 2008-10-15
• Last updated: 2012-01-24
• Results posted: 2012-01-19

Locations

39 sites across 1 country: United States